Published in Am J Pathol on November 01, 1993
The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol (1997) 2.29
Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol Cell Biol (2000) 2.27
The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol (1997) 2.03
Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol (1995) 1.85
Intestinal epithelial restitution. Involvement of specific laminin isoforms and integrin laminin receptors in wound closure of a transformed model epithelium. Am J Pathol (1997) 1.17
Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring. Am J Pathol (2010) 1.07
Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J Clin Invest (1995) 0.98
Cellular and Molecular Characteristics of Scarless versus Fibrotic Wound Healing. Dermatol Res Pract (2010) 0.97
Matrix control of scarring. Cell Mol Life Sci (2011) 0.93
Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. Am J Pathol (1994) 0.93
Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. J Clin Invest (1995) 0.92
Cytoskeleton responses in wound repair. Cell Mol Life Sci (2012) 0.91
Epithelial integrins with special reference to oral epithelia. J Dent Res (2011) 0.90
Fibronectin and alpha5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin potentiation of T cell lymphokine-driven keratinocyte hyperproliferation in psoriasis. J Clin Invest (1998) 0.90
Expression of fibronectin and tenascin as a demonstration of vital reaction in rat skin and muscle. Int J Legal Med (2003) 0.89
Induction of E-selectin-dependent leukocyte recruitment by mast cell degranulation in human skin grafts transplanted on SCID mice. Am J Pathol (1996) 0.86
Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing. Neoplasia (2004) 0.85
Expression of epithelial adhesion proteins and integrins in chronic inflammation. Am J Pathol (1995) 0.85
Demonstration of apoptosis in human skin injuries as an indicator of vital reaction. Int J Legal Med (2002) 0.84
Modulation of intracellular calcium levels inhibits secretion of collagenase 1 by migrating keratinocytes. Mol Biol Cell (1997) 0.84
Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model. J Clin Invest (1996) 0.84
Immunohistochemical monitoring of wound healing in antibiotic treated Buruli ulcer patients. PLoS Negl Trop Dis (2014) 0.84
Focal Contact and Hemidesmosomal Proteins in Keratinocyte Migration and Wound Repair. Adv Wound Care (New Rochelle) (2014) 0.83
Fibronectin matrix mimetics promote full-thickness wound repair in diabetic mice. Tissue Eng Part A (2013) 0.82
The role of fibronectin in corneal wound healing explored by a physician-scientist. Jpn J Ophthalmol (2012) 0.79
Proteomic analysis of gingival tissue and alveolar bone during alveolar bone healing. Mol Cell Proteomics (2013) 0.77
Differential distribution of elastic tissue in human natural skin and tissue-engineered skin. J Mol Histol (2004) 0.76
Phenotypic characterization of keratinocytes migrated from polymer support - in vitro study. J Mater Sci Mater Med (1997) 0.75
Concentration of fibrin and presence of plasminogen affect proliferation, fibrinolytic activity, and morphology of human fibroblasts and keratinocytes in 3D fibrin constructs. Tissue Eng Part A (2014) 0.75
Expression of integrin receptors and ICAM-1 on keratinocytes in vivo and in an in vitro reconstructed epidermis: effect of sodium dodecyl sulphate. Arch Dermatol Res (1995) 0.75
Epidermal Cells Expressing Putative Cell Markers in Nonglabrous Skin Existing in Direct Proximity with the Distal End of the Arrector Pili Muscle. Stem Cells Int (2016) 0.75
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
A severe combined immunodeficiency mutation in the mouse. Nature (1983) 13.99
VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol (1990) 7.62
Integrins and other cell adhesion molecules. FASEB J (1990) 7.28
Laminin receptor on platelets is the integrin VLA-6. Nature (1988) 4.91
Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem (1987) 4.87
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res (1990) 4.22
Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol (1991) 3.91
The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol (1990) 3.82
Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol (1989) 3.44
A monoclonal antibody detaches embryonic skeletal muscle from extracellular matrices. J Cell Biol (1982) 3.23
Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem (1989) 2.71
Induction of tenascin in healing wounds. J Cell Biol (1988) 2.45
Ultrastructural localization of fibronectin and laminin in the basement membranes of the murine kidney. J Cell Biol (1980) 2.42
Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell (1987) 2.41
Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem (1988) 2.23
Distribution of fibronectin during wound healing in vivo. J Invest Dermatol (1981) 2.14
Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol (1982) 2.10
Analysis of the tumor-associated antigen TSP-180. Identity with alpha 6-beta 4 in the integrin superfamily. J Biol Chem (1989) 1.88
Extracellular matrix regulates expression of the TGF-beta 1 gene. J Cell Biol (1993) 1.84
Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol (1990) 1.66
Wound repair, keratinocyte activation and integrin modulation. J Cell Sci (1992) 1.60
Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest (1992) 1.58
Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest (1989) 1.52
Laminin inhibits human keratinocyte migration. J Cell Physiol (1988) 1.46
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol (1991) 1.42
Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest (1993) 1.42
Integrin expression during human epidermal development in vivo and in vitro. Development (1991) 1.41
Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol (1993) 1.39
Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol (1988) 1.32
Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex. J Biol Chem (1985) 1.31
Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol (1992) 1.31
Transforming growth factor-beta switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J Biol Chem (1989) 1.30
Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol (1991) 1.26
Integrins of normal human epidermis: differential expression, synthesis and molecular structure. Br J Dermatol (1990) 1.20
Fibronectin promotes epithelial migration of cultured rabbit cornea in situ. J Cell Biol (1983) 1.18
Detection of basement membrane zone antigens during epidermal wound healing in pigs. J Invest Dermatol (1981) 1.16
Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol (1985) 1.12
Integrins in the wounded and unwounded stratified squamous epithelium of the cornea. Invest Ophthalmol Vis Sci (1993) 1.11
Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin. J Clin Invest (1992) 1.10
Cutaneous wound healing: a model for cell-matrix interactions. J Am Acad Dermatol (1985) 1.09
Activation of human keratinocyte migration on type I collagen and fibronectin. J Cell Sci (1990) 1.03
Altered processing of integrin receptors during keratinocyte activation. Exp Cell Res (1991) 1.00
Regulation of integrin-type cell adhesion receptors by cytokines. J Biol Chem (1991) 0.99
Activation of rabbit keratinocyte fibronectin receptor function in vivo during wound healing. J Invest Dermatol (1986) 0.98
Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor-mediated repair. J Clin Invest (1992) 0.98
Wound repair. Curr Opin Cell Biol (1989) 0.97
Fibronectin receptors of human keratinocytes and their expression during cell culture. J Cell Biol (1987) 0.93
Fibrinogen and fibronectin as substrates for epidermal cell migration during wound closure. J Cell Sci (1983) 0.93
Fibronectin beneath reepithelializing epidermis in vivo: sources and significance. J Invest Dermatol (1983) 0.92
Characterization of tenascin secreted by human melanoma cells. Cancer Res (1991) 0.91
Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol (1991) 0.91
Overexpression of extracellular matrix receptors (VLA-3, 5 and 6) on psoriatic keratinocytes. Br J Dermatol (1991) 0.89
VLA protein expression on epidermal cells (keratinocytes, Langerhans cells, melanocytes): a light and electron microscopic immunohistochemical study. Br J Dermatol (1991) 0.86
Altered glycosylation and cell surface expression of beta 1 integrin receptors during keratinocyte activation. J Cell Sci (1992) 0.86
Wound healing in foetal sheep: a histological and electron microscope study. Br J Plast Surg (1992) 0.82
IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J Immunol (1992) 0.82
Models of wound healing. J Trauma (1990) 0.78
The activated keratinocyte: up regulation of cell adhesion and migration during wound healing. J Trauma (1990) 0.77
Wound healing of human skin transplanted on to the nude mouse. Br J Dermatol (1985) 0.76
Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet (1979) 7.28
Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 4.24
Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res (1990) 4.22
Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol (1993) 3.74
Specific antigen in serum of patients with colon carcinoma. Science (1981) 3.68
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 3.46
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med (2001) 3.24
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development (1994) 2.71
Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science (1993) 2.71
The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse. Br J Pharmacol (1969) 2.54
N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res (2001) 2.47
CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J Exp Med (1992) 2.38
E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol (2000) 2.36
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med (1993) 2.24
Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol (1997) 2.23
Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23
Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res (1982) 2.21
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene (2008) 2.19
Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol (1997) 2.17
Intercostal arteriovenous fistula due to pleural biopsy. Thorax (1990) 2.15
Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A (1991) 2.11
Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res (1997) 2.11
Molecular and functional aspects of PECAM-1/CD31. Immunol Today (1994) 2.04
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest (1998) 1.91
Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature (1993) 1.90
Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg (1994) 1.89
Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A (1989) 1.88
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. Cancer Res (1994) 1.86
Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res (1985) 1.85
Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J (1989) 1.84
A new immunologic marker for human Langerhans cells. N Engl J Med (1981) 1.79
Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol (1982) 1.76
Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res (2001) 1.75
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 1.74
Characterization of Langerhans cells by the use of monoclonal antibodies. Lab Invest (1981) 1.73
Effects of alpha-hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. J Am Acad Dermatol (1996) 1.72
Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci U S A (1999) 1.68
Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med (1999) 1.67
Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci U S A (1989) 1.67
Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci U S A (1993) 1.63
Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci (1999) 1.61
Biology of tumor progression in human melanocytes. Lab Invest (1987) 1.61
Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene (2001) 1.59
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol (1979) 1.59
An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med (1996) 1.58
Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol (1993) 1.58
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels. Br J Cancer (2007) 1.57
Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem (1993) 1.55
T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J Exp Med (1994) 1.55
A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J Exp Med (1992) 1.55
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci U S A (1991) 1.54
Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. Proc Natl Acad Sci U S A (1986) 1.54
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma. Hum Gene Ther (1998) 1.51
Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem (1996) 1.50
Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol (1998) 1.50
Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49
Human beta-filamin is a new protein that interacts with the cytoplasmic tail of glycoprotein Ibalpha. J Biol Chem (1998) 1.49
Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest (1992) 1.48
Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A (1999) 1.46
Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture. J Immunol (1987) 1.44
Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors. Proc Natl Acad Sci U S A (1986) 1.44
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer (1994) 1.44
Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci (2000) 1.44
Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest (2000) 1.42
Malignant melanoma in situ: an oxymoron whose time has come. Hum Pathol (1998) 1.42
Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest (1993) 1.42
Vinblastine and erythromycin: an unrecognized serious drug interaction. Cancer Chemother Pharmacol (1995) 1.41
Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg (1990) 1.40
Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Res (2001) 1.40
Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol (1993) 1.39
Chronically KIT-stimulated clonally-derived human mast cells show heterogeneity in different tissue microenvironments. J Invest Dermatol (1997) 1.39
Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res (1994) 1.38
Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem (1996) 1.37
Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo. Am J Respir Cell Mol Biol (1993) 1.37
Efficient selection of human tumor growth-inhibiting monoclonal antibodies. J Immunol Methods (1984) 1.37
Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab Invest (1993) 1.36
Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum Gene Ther (2001) 1.36
Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol (1991) 1.35
Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet (1986) 1.34
Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc (1996) 1.33
Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events. J Cell Biol (1990) 1.32
Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet (2004) 1.32
Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol (2001) 1.31
Distribution of integrin cell adhesion receptors in normal and malignant lung tissue. Am J Respir Cell Mol Biol (1992) 1.31
Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell (1993) 1.31
Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. J Clin Immunol (1982) 1.31
Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol (1992) 1.30
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst (1985) 1.30
Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol (2000) 1.29